Advances in Hemophilia A: Expert Guidance and Practical Case Discussions

Gain insights into the latest advances in treatment of hemophilia A, including nonfactor and gene therapies, through expert-guided discussion and case-based examples.
Michael Callaghan, MD
Stacy Croteau Headshot
Stacy E. Croteau, MD, MMS
person default
Cindy A. Leissinger, MD
Guy A. Young, MD

ClinicalThought

With improved therapies, we can reduce the treatment burden of hemophilia A for patients. Here’s my take on how far we have come and where we are going.

Guy A. Young, MD Released: October 16, 2019

Here’s my take on some of the most exciting hemophilia A studies being presented at the upcoming ASH 2019 meeting in Orlando.

person default Cindy A. Leissinger, MD Released: December 3, 2019

Downloadable Slidesets

Learn the current clinical progress and unmet needs in hemophilia A treatment.

Michael Callaghan, MD Stacy Croteau Headshot Stacy E. Croteau, MD, MMS person default Cindy A. Leissinger, MD Guy A. Young, MD Released: December 5, 2019

Review of the current and emerging factors including extended half-life factors, immunogenicity, and how to use pharmacokinetics to individualize therapy.

Michael Callaghan, MD Stacy Croteau Headshot Stacy E. Croteau, MD, MMS person default Cindy A. Leissinger, MD Guy A. Young, MD Released: December 5, 2019

Learn about emicizumab and its impact on monitoring assays and surgical management in hemophilia A.

Michael Callaghan, MD Stacy Croteau Headshot Stacy E. Croteau, MD, MMS person default Cindy A. Leissinger, MD Guy A. Young, MD Released: December 5, 2019

Learn the rationale and efficacy and safety data for emerging extended half-life factor replacement and nonfactor replacement strategies for hemophilia A, including mimetics, rebalancers, and gene therapy.

Michael Callaghan, MD Stacy Croteau Headshot Stacy E. Croteau, MD, MMS person default Cindy A. Leissinger, MD Guy A. Young, MD Released: December 5, 2019

Explore practical issues in hemophilia A, including managing breakthrough bleeds, surgery, immune tolerance induction, and previously untreated patients.

Michael Callaghan, MD Stacy Croteau Headshot Stacy E. Croteau, MD, MMS person default Cindy A. Leissinger, MD Guy A. Young, MD Released: December 5, 2019

Clinician Resource

Download this quick guide to the latest agents and currently recruiting trials for patients with hemophilia A.

Guy A. Young, MD Released: December 5, 2019
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
Genentech

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?